Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 2,290,500 | 2,386,300 | 2,530,300 | 2,456,000 | 2,463,000 |
| Cost of Goods | 542,200 | 618,300 | 659,600 | 592,700 | 662,800 |
| Gross Profit | 1,748,300 | 1,768,000 | 1,870,700 | 1,863,300 | 1,800,200 |
| Operating Expenses | 1,190,000 | 1,409,400 | 1,712,500 | 1,277,100 | 1,293,300 |
| Operating Income | 558,500 | 358,900 | 158,800 | 586,900 | 507,700 |
| Other Income | -93,700 | -67,300 | -300,000 | 121,200 | -69,400 |
| Pre-tax Income | 464,800 | 291,600 | -141,200 | 708,100 | 438,300 |
| Income Tax | 71,400 | 42,700 | -72,900 | 114,800 | 50,700 |
| Net Income Continuous | 393,400 | 248,900 | -68,300 | 593,300 | 387,600 |
| Minority Interests | N/A | -800 | -200 | 1,700 | -300 |
| Net Income | $393,400 | $249,700 | $-68,100 | $591,600 | $387,900 |
| EPS Basic Total Ops | 2.71 | 1.71 | -0.47 | 4.09 | 2.69 |
| EPS Basic Continuous Ops | 2.71 | 1.71 | -0.47 | 4.10 | 2.68 |
| EPS Diluted Total Ops | 2.70 | 1.70 | -0.47 | 4.07 | 2.67 |
| EPS Diluted Continuous Ops | 2.70 | 1.70 | -0.47 | 4.08 | 2.67 |
| EPS Diluted Before Non-Recurring Items | N/A | 2.95 | 4.36 | 4.02 | 3.40 |
| EBITDA(a) | $750,100 | $530,500 | $283,800 | $704,300 | $620,000 |